Evidence map›Paper›PMID 38931195›Full record

ArticleNutrients2024

Artificial and Natural Sweeteners Biased T1R2/T1R3 Taste Receptors Transactivate Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition of Metastatic Phenotype.

Elizabeth Skapinker, Rashelle Aldbai, Emilyn Aucoin, Elizabeth Clarke, Mira Clark, Daniella Ghokasian, Haley Kombargi, Merlin J Abraham, Yunfan Li, David A Bunsick and 2 more

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elizabeth SkapinkerFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.
Rashelle AldbaiFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.
Emilyn AucoinFaculty of Science, Biology (Biomedical Science), York University, Toronto, ON M3J 1P3, Canada.ORCID 0009-0005-0327-2188
Elizabeth ClarkeFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.
Mira ClarkFaculty of Arts and Science, Queen's University, Kingston, ON K7L 3N9, Canada.ORCID 0009-0000-6128-181X
Daniella GhokasianFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.
Haley KombargiFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.ORCID 0009-0002-5268-6668
Merlin J AbrahamFaculty of Health Sciences, Queen's University, Kingston, ON K7L 3N9, Canada.
Yunfan LiFaculty of Arts and Science, Queen's University, Kingston, ON K7L 3N9, Canada.
David A BunsickDepartment of Biomedical & Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
Leili BaghaieDepartment of Biomedical & Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0009-0000-7135-2570
Myron R SzewczukDepartment of Biomedical & Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.ORCID 0000-0001-8471-5481

Funding

Natural Sciences and Engineering Research Council of Canada (NSERC) Grant # RGPIN-2020-03869
6 · The paper itself

Abstract

Understanding the role of biased taste T1R2/T1R3 G protein-coupled receptors (GPCR) agonists on glycosylated receptor signaling may provide insights into the opposing effects mediated by artificial and natural sweeteners, particularly in cancer and metastasis. Sweetener-taste GPCRs can be activated by several active states involving either biased agonism, functional selectivity, or ligand-directed signaling. However, there are increasing arrays of sweetener ligands with different degrees of allosteric biased modulation that can vary dramatically in binding- and signaling-specific manners. Here, emerging evidence proposes the involvement of taste GPCRs in a biased GPCR signaling crosstalk involving matrix metalloproteinase-9 (MMP-9) and neuraminidase-1 (Neu-1) activating glycosylated receptors by modifying sialic acids. The findings revealed that most natural and artificial sweeteners significantly activate Neu-1 sialidase in a dose-dependent fashion in RAW-Blue and PANC-1 cells. To confirm this biased GPCR signaling crosstalk, BIM-23127 (neuromedin B receptor inhibitor, MMP-9i (specific MMP-9 inhibitor), and oseltamivir phosphate (specific Neu-1 inhibitor) significantly block sweetener agonist-induced Neu-1 sialidase activity. To assess the effect of artificial and natural sweeteners on the key survival pathways critical for pancreatic cancer progression, we analyzed the expression of epithelial-mesenchymal markers, CD24, ADLH-1, E-cadherin, and N-cadherin in PANC-1 cells, and assess the cellular migration invasiveness in a scratch wound closure assay, and the tunneling nanotubes (TNTs) in staging the migratory intercellular communication. The artificial and natural sweeteners induced metastatic phenotype of PANC-1 pancreatic cancer cells to promote migratory intercellular communication and invasion. The sweeteners also induced the downstream NFκB activation using the secretory alkaline phosphatase (SEAP) assay. These findings elucidate a novel taste T1R2/T1R3 GPCR functional selectivity of a signaling platform in which sweeteners activate downstream signaling, contributing to tumorigenesis and metastasis via a proposed NFκB-induced epigenetic reprogramming modeling.

Indexed as

Epithelial-Mesenchymal TransitionMatrix Metalloproteinase 9Neoplasm MetastasisReceptors, G-Protein-CoupledSweetening AgentsAnimalsCell Line, TumorCell MovementGlycosylationHumansNeuraminidasePhenotypeSignal TransductionTasteMatrix Metalloproteinase 9NEU1 protein, humanNeuraminidaseReceptors, G-Protein-CoupledSweetening Agentstaste receptors, type 1epithelial-mesenchymal transitionglycosylated receptorG protein-coupled receptorsmigrationpancreatic cancersweetenersT1R2/T1R3tunneling nanotubes

Identifiers

PMID38931195
PMCPMC11206856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.